Why Is Depo-SubQ Provera 104 So Hard to Find? [Explained for 2026]

If you've recently tried to pick up Depo-SubQ Provera 104 at a pharmacy and walked away empty-handed, you're not alone. This subcutaneous contraceptive injection — manufactured exclusively by Pfizer — has a reputation for being difficult to find at retail pharmacies, even though it is not on the FDA's formal drug shortage list. So what's going on?

What Is Depo-SubQ Provera 104?

Depo-SubQ Provera 104 (medroxyprogesterone acetate 104 mg/0.65 mL) is a brand-name injectable contraceptive and endometriosis pain treatment made by Pfizer. Unlike its sister product Depo-Provera CI, which is injected intramuscularly, Depo-SubQ Provera 104 is injected subcutaneously — just under the skin — into the thigh or abdomen every 12 to 14 weeks (approximately every 3 months).

It is FDA-approved for two indications: prevention of pregnancy and management of endometriosis-associated pain. Importantly, there is currently no FDA-approved generic version of Depo-SubQ Provera 104 — meaning patients must obtain the brand-name product at whatever price and availability Pfizer and pharmacies dictate.

Why Is There No Generic Available?

The FDA has not approved any generic version of the subcutaneous 104 mg formulation. (Note: Generic versions of the 150 mg intramuscular Depo-Provera CI do exist, but they are a different product.) Without generic competition, pharmacy stocking decisions for Depo-SubQ Provera 104 are driven entirely by demand — and for a drug that's given only once every three months, many pharmacies simply don't stock it routinely.

Why Don't Most Pharmacies Stock It?

Pharmacies typically stock medications based on demand volume, refrigeration requirements, and shelf life. Depo-SubQ Provera 104 presents some stocking challenges:

Low prescription volume: Because this is a brand-only injectable given quarterly, many pharmacies see only a handful of prescriptions per month — not enough to justify keeping stock on shelves.

Demand-based ordering: Many pharmacies only order it when a patient has a prescription in hand, which means a 1–3 day wait for the medication to be ordered and received.

Rural and underserved areas: Supply gaps are especially common in smaller towns and rural communities where overall prescription volume is lower.

Specialty clinic administration: Many patients receive this injection at their OB/GYN or women's health clinic rather than at a retail pharmacy, further reducing retail demand.

Has the December 2025 Meningioma Warning Affected Availability?

In December 2025, the FDA approved a label update for Depo-SubQ Provera 104 (and its IM counterpart Depo-Provera CI) adding a warning about a potential increased risk of meningioma — a typically benign brain tumor — associated primarily with long-term use. This change was driven by data from a large BMJ study and a JAMA Neurology study identifying elevated meningioma risk with prolonged use of injectable medroxyprogesterone acetate.

While this label change has prompted some patients and providers to reassess use, it did not result in an FDA recall or restriction on availability. The drug remains on the market. However, some providers have shifted patients to alternative contraceptive options, which may have slightly decreased overall demand — but this has not made the drug easier to find at individual pharmacies.

38,404+ patients found their medications in stock

38K+

Find Depo-SubQ Provera 104 In Stock Today →

Is Depo-SubQ Provera 104 on the FDA Shortage List?

As of 2026, Depo-SubQ Provera 104 is not listed on the FDA Drug Shortage Database. The national supply of medroxyprogesterone acetate injectable remains intact. What patients experience is not a formal shortage but rather inconsistent retail pharmacy stocking — particularly in rural and underserved areas where demand-based ordering leaves many pharmacies without routine stock.

What Can You Do If Your Pharmacy Doesn't Have It?

The key is knowing where to look and how to search efficiently. Calling pharmacies one by one is time-consuming and frustrating. A smarter approach is to use a service like medfinder, which calls pharmacies near you to check real-time availability so you don't have to.

You can also read our guide on how to find Depo-SubQ Provera 104 in stock near you for step-by-step tips and tools.

Skip the calls, skip the stress.

Find Depo-SubQ Provera 104 In Stock Today →

50K+

Medications
Found

99%

Success
Rate

6+

Hours saved
on average

Quick Tips to Find Depo-SubQ Provera 104

Call your OB/GYN or women's health clinic first — many keep it in stock for in-office administration.

Check with specialty pharmacies or compounding pharmacies, which may stock it more reliably.

Ask your pharmacist to order it in advance — most pharmacies can have it within 1–3 business days.

Use medfinder to locate which pharmacies near you currently have it in stock.

Should You Consider Switching to Depo-Provera CI Instead?

If you're routinely having trouble finding Depo-SubQ Provera 104, it may be worth talking to your doctor about switching to Depo-Provera CI (150 mg intramuscular) or another long-acting reversible contraceptive. See our full guide on alternatives to Depo-SubQ Provera 104 if you're unable to fill your prescription.

The Bottom Line

Depo-SubQ Provera 104 is hard to find not because of a formal shortage, but because it's a brand-only injectable that many pharmacies don't routinely stock. The good news is that the national supply is intact, which means the drug is out there — you just need to know where to look. medfinder can help by calling pharmacies near you to check real-time stock, saving you the frustrating phone tag.